SlideShare a Scribd company logo
1 of 28
Download to read offline
1
Raising Capital for
Medical Device
Development
Challenges for
Inventors and Investors
Presented by !
Robert Stathopulos!
!
President, Product Development Technology, Inc.!
Sponsor & Advisor, Entrepreneurs University!
!
02 April 2013!
Raising Capital for Medical Device Development
2© 2013 Product Development Technology, Inc.
•  Established companies develop existing device iterations
•  Start-up companies develop most new devices categories
•  Innovation has outstripped ability to assess performance
•  Dissemination of innovation delayed by outcomes validation
Product Innovation
Raising Capital for Medical Device Development
3
MEDICAL DEVICE DEVELOPMENT
Low Impact
on Clinical Utility
High Impact
on Clinical Utility
MARGINAL
INNOVATION
'Existing' Technology
applied to 'Existing' Medical Use
LOWEST UNCERTAINTY
THERAPEUTIC
INNOVATION
'Existing' Technology
applied to 'New' Medical Use
MEDIUM to HIGH UNCERTAINTY
High Impact
on Technology-in-Use
Low Impact
on Technology-in-Use
TECHNOLOGICAL
INNOVATION
'New' Technology
applied to 'Existing' Medical Use
LOW to MEDIUM UNCERTAINTY
RADICAL
INNOVATION
'New' Technology
applied to 'New' Medical Use
HIGHEST UNCERTAINTY
© 2013 Product Development Technology, Inc.
MODEL OF PRODUCT INNOVATION
Raising Capital for Medical Device Development
4
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
"New" Medical
Technology
"Existing"
Clinical Use
"Existing" Medical
Technology
"Existing"
Clinical Use
"Existing" Medical
Technology
"New"
Clinical Use
"New" Medical
Technology
"New"
Clinical Use
HIGH
LOW
UNCERTAINTY
SCALE
"EXISTING"
CLINICAL USE
Domain
"NEW"
CLINICAL USE
Domain
LEVELS OF DEVELOPMENT RISK
Raising Capital for Medical Device Development
5
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
LEVELS OF DEVELOPMENT RISK
HIGH
LOW
UNCERTAINTY
SCALE
Plateau of
Status Quo
(We do not wish
to change anything)
Plateau of
Utility Promotion
(We find new means
for old ways)
Plateau of
Everything Changes
(We find new means
with new ways)
"EXISTING"
CLINICAL USE
Domain
"NEW"
CLINICAL USE
Domain
Plateau of
Technology Promotion
(We do it
Smaller-Better-
Faster-Cheaper)
Raising Capital for Medical Device Development
6
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
LEVELS OF TECHNOLOGY
READINESS
Basic Principles
Observed
Speculative
Application
Formulated
Critical Function
Proof-of-Concept
Breadboard
Verification
in Laboratory
Breadboard
Verification
in Simulated Use
System Prototype
Verification
in Simulated Use
System Prototype
Verification
in Actual Use
Final Product
Validation
in Actual Use
Final Product
Validation
in Marketplace
STEP #9
STEP #8
STEP #7
STEP #6
STEP #5
STEP #4
STEP #3
STEP #2
STEP #1
VERIFICATION
PHASE
FEASIBILITY
PHASE
Raising Capital for Medical Device Development
7
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
Inventor
Venture
Team
Seed
Investors
Compliance
Officers
Device
Users
Patent
Attorneys
Key
Suppliers
Family
Members
Angel
Investors
WHAT KEEPS THE INVENTOR UP AT NIGHT?
Raising Capital for Medical Device Development
8
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
WHAT KEEPS THE INVESTOR UP AT NIGHT?
Inventor
Angel
Investors
Raising Capital for Medical Device Development
9
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
INVENTOR PERSPECTIVE
Compelling Product Concept
Imperative: “Do It Right”
Goal: “Get Product to Market”
Supplies Vision and
Perspiration
Raising Capital for Medical Device Development
10
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
INVESTOR PERSPECTIVE
Compelling Investment Opportunity!
!
Imperative: “Get It Done”!
"
Goal: “Move Venture to Exit”"
"
Supplies Cash and Credibility"
Raising Capital for Medical Device Development
11
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
INVENTOR + INVESTOR
as
THE ODD COUPLE
Raising Capital for Medical Device Development
12
MEDICAL DEVICE DEVELOPMENT
•  Evidence – Product Functions as Intended
•  Evidence – Product has Clinical Utility
•  Evidence – Product can be Profitable
•  Evidence – Business Model is Scalable
•  Evidence – Product has Proprietary Barrier
•  Evidence – Development Path is Viable
•  Evidence – Regulatory Path is Viable
•  Evidence – Reimbursement Path is Viable
•  Evidence – Venture Team is Competent
•  Evidence – Venture Team has Skin-in-the-Game
•  Evidence – Use of Proceeds will be Effective
•  Evidence – Investor Exit is Plausible
•  Evidence – Seed Stage Funding is Clean
•  Evidence – Product Design is Documented
© 2013 Product Development Technology, Inc.
INVENTOR CHALLENGES
Raising Capital for Medical Device Development
13
MEDICAL DEVICE DEVELOPMENT
•  Will this Venture FIT into my PORTFOLIO?
•  Are the Product and its Market REAL?
•  Is the Technology behind the Product READY?
•  Will the Product have the Cache to WIN?
•  Is the Expected Return WORTH the Investment?
•  Will the Venture Team meet its COMMITMENTS?
•  Is there a viable path to US Market CLEARANCE?
•  Is there a viable path to US REIMBURSEMENT?
•  Will Due Diligence confirm the Inventor CLAIMS?
© 2013 Product Development Technology, Inc.
INVESTOR CHALLENGES
Raising Capital for Medical Device Development
14
MEDICAL DEVICE DEVELOPMENT
INVESTOR MINEFIELD
•  Return on Investment based on liquidity event
•  Novel Products tied to emerging or untried markets
•  Venture is pre-revenue with no customer history
•  Products in Development susceptible to market changes
•  Product Knowledge held by very few
•  Further Funding limited if key milestones missed
•  Development Cycle has high cash-burn rate
•  Venture Valuations are speculative or intuitive
•  Minority Shareholders have little control
•  Entrepreneurs poor at anticipating future problems
© 2013 Product Development Technology, Inc.
Raising Capital for Medical Device Development
15
MEDICAL DEVICE DEVELOPMENT
INVENTOR MINEFIELD
•  PATENT CLAIMS disallowance
•  MARKET LANDSCAPE change
•  REGULATORY LANDSCAPE change
•  REIMBURSEMENT LANDSCAPE change
•  PRODUCT COST escalation
•  CLINICAL CLAIMS disallowance
•  KEY SUPPLIER bankruptcy
•  VENTURE FUNDING difficulties
© 2013 Product Development Technology, Inc.
Raising Capital for Medical Device Development
16
MEDICAL DEVICE DEVELOPMENT
TYPES OF MEDICAL DEVICES
© 2013 Product Development Technology, Inc.
In-Vitro
Diagnostic
Device
Medical
Capital
Equipment
Medical
Device
Software
Active
Medical
Device
Disposable
Medical
Device
Device Electronics Software
Software
Disposable Hardware SoftwareElectronics
Disposable
DisposableAssay SoftwareInstrument
Raising Capital for Medical Device Development
17
MEDICAL DEVICE DEVELOPMENT
DEVICE DEVELOPMENT PROCESS
© 2013 Product Development Technology, Inc.
CONCEPT
DEVELOPMENT
INVESTMENT
GATE #2
INVESTMENT
GATE #1
SEED
ROUND
FOUNDERS
ROUND
CONCEPT
DEVELOPMENT
PROTOTYPE
DEVELOPMENT
INVESTMENT
GATE #2
INVESTMENT
GATE #3
INVESTMENT
GATE #1
SEED
ROUND
ANGEL
ROUND 1
ANGEL
ROUND 2
FOUNDERS
ROUND
CLASS II
MEDICAL
DEVICE
CLASS III
MEDICAL
DEVICE
12 to 24 Months 12 to 24 Months
12 to 24 Months
$250,000 $250,000
PRE-CLINICAL
DEVELOPMENT
ANGEL
ROUND 2
ANGEL
EXIT
ANGEL
ROUND 3
CORPORATE
ACQUISITION
12 to 24 Months
24 to 48 Months
PROTOTYPE
DEVELOPMENT
TECHNOLOGY
DEVELOPMENT
INVESTMENT
GATE #3
12 to 24 Months12 to 24 Months
GOVERNMENT
GRANTS
ANGEL
ROUND 1
12 to 24 Months
ANGEL
EXIT
CORPORATE
ACQUISITION
36 to 72 Months
(3 to 6 Years)
72 to 144 Months
(6 to 12 Years)
$2,000,000
to
$3,000,000
$2,000,000
to
$3,000,000
$250,000$250,000
INVESTMENT
GATE #4
INVESTMENT
GATE #5
$3,000,000
to
$4,000,000
$3,500,000
to $5,000,000
CLINICAL
DEVELOPMENT
CLINICAL
DEVELOPMENT
$7,000,000
to
$10,500,000
$1,000,000
to
$2,000,000
$500,000
to
$1,000,000
$1,000,000
to
$1,500,000
Raising Capital for Medical Device Development
18
MEDICAL DEVICE DEVELOPMENT
DEVICE DEVELOPMENT PROCESS
© 2013 Product Development Technology, Inc.
CLINICAL
DEVELOPMENT
MANUFACTURING
DEVELOPMENT
MARKET
DEVELOPMENT
CORPORATE
ACQUISITION
PRODUCT
INTRODUCTION
INVESTOR
EXITVC
ROUND 1
VC
ROUND 2
VC
ROUND 3
12 to 24 Months 12 to 24 Months 12 to 24 Months
External vs. Internal
Manufacturing
$2,000,000
to
$5,000,000
$1,000,000
to
$3,000,000
$1,000,000
to
$3,000,000
External vs. Internal
Sales Team
Not Reimbursed
to Reimbursed
Funding
Source
Switch
VENTURE CAPITALIST FUNDING
> Later Stage Venture
> Lower Risk Investment
> Larger Investments
ANGEL INVESTOR FUNDING
> Early Stage Venture
> Higher Risk Investment
> Smaller Investments
Raising Capital for Medical Device Development
19
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
PRE-MONEY VALUATION
for
EARLY STAGE VENTURE
EXECUTION
STRATEGY=
=
PRODUCT
IDEA
PRE-MONEY
VALUATION
$750,000 to $1,500,000 (Typically)
Weak Idea 1
Fair Idea 5
Good Idea 10
Great Idea 15
Brillant Idea 20
Weak Execution $1,000
Fair Execution $10,000
Good Execution $100,000
Great Execution $1,000,000
Brillant Execution $10,000,000
Raising Capital for Medical Device Development
20
MEDICAL DEVICE DEVELOPMENT
CORPORATE ATTRACTION
to EARLY STAGE VENTURE
•  Exposure to emerging technology
•  Access to specialized knowledge
•  Understanding of emerging market
•  Access to entrepreneurial talent
•  Investment in potential acquisition
•  Blocking competitor acquisition
•  Access to new customer or distributor
•  Access to complementary technology
© 2013 Product Development Technology, Inc.
Raising Capital for Medical Device Development
21
MEDICAL DEVICE DEVELOPMENT
FINANCIAL VENTURE
•  Exit Value based on ‘future
profit generation’
•  Use Proceeds to drive growth
•  Venture has revenue, profit,
growth
•  Profitability-Driven Acquisition
•  Sale limited by profit-
generating capability
STRATEGIC VENTURE
•  Exit Value based on ‘asset or
capability’
•  Use Proceeds to build asset or
capability
•  Venture leverages acquirer’s
operation; too costly or time-
consuming to copy
•  Synergy-Driven Acquisition
•  Sale limited by business synergy
effect
CORPORATE VALUATION
of EARLY STAGE VENTURE
© 2013 Product Development Technology, Inc.
Raising Capital for Medical Device Development
22© 2013 Product Development Technology, Inc.
The Drama of !
REGULATORY APPROVAL !
& INSURANCE REIMBURSEMENT!
Raising Capital for Medical Device Development
23
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
US REGULATORY
PATHWAY
PROTOTYPE
DEVELOPMENT
BENCH
TESTING
ANIMAL
TESTING
PRE-SUBMISSION
MEETING
PILOT
CLINICAL
US MARKET
CLEARANCE
IDE
SUBMISSION
IDE
SUBMISSION
PIVOTAL
CLINICAL
APPLICATION
REVIEW
US MARKET
CLEARANCE
APPLICATION
REVIEW
US MARKET
APPROVAL
> Traditional 510(k)
> Special 510(k)
> Abbreviated 510(k)
> Traditional PMA
> Modular PMA
> Streamlined PMA
> Product Development Protocol
> Humanitarian Device Exemption
> De Novo 510(k)
CLASS I
DEVICE
CLASS II
DEVICE
(Not Significant Risk)
CLASS II
DEVICE
(Significant Risk)
CLASS III
DEVICE
510(K)
APPLICATION
PMA
APPLICATION
Raising Capital for Medical Device Development
24
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
EU REGULATORY PATHWAY
Select
EC Directive
Classify
Medical Device
Select
ISO Certified
Manufacturer
Prepare
Technical File
or Design Dossier
Select
Notified Body
Audit
Technical File
or Design Dossier
Prepare
Declaration
of Conformity
Affix
CE Mark
Raising Capital for Medical Device Development
25
MEDICAL DEVICE DEVELOPMENT
CMS
Scrutiny
CLINICAL
OUTCOME
MEDICAL
SAFETY
ECONOMIC
OUTCOME
FDA
Scrutiny
MEDICAL
SAFETY
CLINICAL
EFFICACY
•  FDA validates safety and efficacy
of new device
•  CMS considers patient need and
medical necessity
•  CMS will not approve new costly
procedure or device if current
treatment gives similar outcome
•  CMS will approve new device with
demonstrably superior results
•  CMS will approve new procedure
if greatly needed and no current
alternatives
•  Health economics must justify
more costly device with better
patient outcome
© 2013 Product Development Technology, Inc.
INSURANCE REIMBURSEMENT
Raising Capital for Medical Device Development
26
MEDICAL DEVICE DEVELOPMENT
•  FDA Clearance insufficient for Reimbursement
•  Reimbursement is success driver for new technology
•  Medicine-Based Evidence ranks Quality of Evidence
•  Clinical effectiveness of device for Patients
•  Cost effectiveness of device for Stakeholders
•  No guarantee for Coverage or sufficient Payment
© 2013 Product Development Technology, Inc.
INSURANCE REIMBURSEMENT
BENEFITCOST
TECHNOLOGY
ASSESSMENT
• PATIENT
• PROVIDER
• PURCHASER
• PAYER
• REGULATOR
• SOCIETY
• PATIENT
• PROVIDER
• PURCHASER
• PAYER
• REGULATOR
• SOCIETY
Raising Capital for Medical Device Development
27
MEDICAL DEVICE DEVELOPMENT
•  Device receiving 510(k)
Clearance is substantially
equivalent to currently
marketed product
•  Device would fall under
current reimbursement
coverage, code and
payment constraints
•  Argument for higher
payment for Device is
illogical
© 2013 Product Development Technology, Inc.
INSURANCE REIMBURSEMENT
REGULATORY
PATHWAY
REIMBURSEMENT
PATHWAY
Pathway
Synchronization
Raising Capital for Medical Device Development
28
MEDICAL DEVICE DEVELOPMENT
© 2013 Product Development Technology, Inc.
“If everything seems under control,
you’re just not going fast enough.”
--Mario Andretti

More Related Content

What's hot

Abbott overview medical device human factors standards
Abbott overview medical device human factors standardsAbbott overview medical device human factors standards
Abbott overview medical device human factors standardsJones Wu
 
Regulatory approval process for medical Devices
Regulatory approval process for medical DevicesRegulatory approval process for medical Devices
Regulatory approval process for medical DevicesThe QCCP
 
Developing an Effective Ad-Promo Review Process
Developing an Effective Ad-Promo Review ProcessDeveloping an Effective Ad-Promo Review Process
Developing an Effective Ad-Promo Review ProcessDale Cooke
 
Regulatory requirement and approval procedure of food in india
Regulatory requirement and approval procedure of food in indiaRegulatory requirement and approval procedure of food in india
Regulatory requirement and approval procedure of food in indiaAtul Bhombe
 
21 CFR Part 4 - CGMP for Combination Products
21 CFR Part 4 - CGMP for Combination Products21 CFR Part 4 - CGMP for Combination Products
21 CFR Part 4 - CGMP for Combination ProductsJasmin NUHIC
 
Medical devices introduction
Medical devices introductionMedical devices introduction
Medical devices introductionSigma
 
Medical device regulatory ppt
Medical device regulatory pptMedical device regulatory ppt
Medical device regulatory pptRohitParkale
 
PhillyCooke eCTD Submissions for Ad-Promo
PhillyCooke eCTD Submissions for Ad-PromoPhillyCooke eCTD Submissions for Ad-Promo
PhillyCooke eCTD Submissions for Ad-PromoDale Cooke
 
The regulation of IVD medical devices
The regulation of IVD medical devicesThe regulation of IVD medical devices
The regulation of IVD medical devicesTGA Australia
 
IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best PracticesCFTCC
 
medical device regulatory approval in USA
medical device regulatory approval in USAmedical device regulatory approval in USA
medical device regulatory approval in USASuraj Pamadi
 
Regulation of medical device in japan
Regulation of medical device in japanRegulation of medical device in japan
Regulation of medical device in japanKrushnaAgnihotri
 
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Akshay Anand
 
Presentation: Manufacturing medical devices
Presentation: Manufacturing medical devicesPresentation: Manufacturing medical devices
Presentation: Manufacturing medical devicesTGA Australia
 

What's hot (20)

Abbott overview medical device human factors standards
Abbott overview medical device human factors standardsAbbott overview medical device human factors standards
Abbott overview medical device human factors standards
 
Regulatory approval process for medical Devices
Regulatory approval process for medical DevicesRegulatory approval process for medical Devices
Regulatory approval process for medical Devices
 
Developing an Effective Ad-Promo Review Process
Developing an Effective Ad-Promo Review ProcessDeveloping an Effective Ad-Promo Review Process
Developing an Effective Ad-Promo Review Process
 
Regulatory requirement and approval procedure of food in india
Regulatory requirement and approval procedure of food in indiaRegulatory requirement and approval procedure of food in india
Regulatory requirement and approval procedure of food in india
 
21 CFR Part 4 - CGMP for Combination Products
21 CFR Part 4 - CGMP for Combination Products21 CFR Part 4 - CGMP for Combination Products
21 CFR Part 4 - CGMP for Combination Products
 
Medical devices
Medical devicesMedical devices
Medical devices
 
Nda and Anda
Nda and AndaNda and Anda
Nda and Anda
 
In vitro diagnostics
In vitro diagnostics In vitro diagnostics
In vitro diagnostics
 
Medical devices introduction
Medical devices introductionMedical devices introduction
Medical devices introduction
 
Medical device regulatory ppt
Medical device regulatory pptMedical device regulatory ppt
Medical device regulatory ppt
 
PhillyCooke eCTD Submissions for Ad-Promo
PhillyCooke eCTD Submissions for Ad-PromoPhillyCooke eCTD Submissions for Ad-Promo
PhillyCooke eCTD Submissions for Ad-Promo
 
The regulation of IVD medical devices
The regulation of IVD medical devicesThe regulation of IVD medical devices
The regulation of IVD medical devices
 
IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best Practices
 
medical device regulatory approval in USA
medical device regulatory approval in USAmedical device regulatory approval in USA
medical device regulatory approval in USA
 
Medical Device Regulations - 510(k) Process
Medical Device Regulations - 510(k) ProcessMedical Device Regulations - 510(k) Process
Medical Device Regulations - 510(k) Process
 
CLINICAL TRIALS OF MEDICAL DEVICES
CLINICAL TRIALS OF MEDICAL DEVICESCLINICAL TRIALS OF MEDICAL DEVICES
CLINICAL TRIALS OF MEDICAL DEVICES
 
Regulation of medical device in japan
Regulation of medical device in japanRegulation of medical device in japan
Regulation of medical device in japan
 
Medical device development
Medical device developmentMedical device development
Medical device development
 
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
 
Presentation: Manufacturing medical devices
Presentation: Manufacturing medical devicesPresentation: Manufacturing medical devices
Presentation: Manufacturing medical devices
 

Viewers also liked

Medical device development lifecycle
Medical device development lifecycleMedical device development lifecycle
Medical device development lifecycleTim Blair
 
Design control FDA requirements
Design control FDA requirementsDesign control FDA requirements
Design control FDA requirementsLatvian University
 
Systems Engineering and Requirements Management in Medical Device Product Dev...
Systems Engineering and Requirements Management in Medical Device Product Dev...Systems Engineering and Requirements Management in Medical Device Product Dev...
Systems Engineering and Requirements Management in Medical Device Product Dev...UBMCanon
 
Common Mistakes in the Medical Device Development Continuum
Common Mistakes in the Medical Device Development ContinuumCommon Mistakes in the Medical Device Development Continuum
Common Mistakes in the Medical Device Development ContinuumNAMSA
 
FDA Design Controls: What Medical Device Makers Need to Know
FDA Design Controls: What Medical Device Makers Need to KnowFDA Design Controls: What Medical Device Makers Need to Know
FDA Design Controls: What Medical Device Makers Need to KnowGreenlight Guru
 
Presentation: Life cycle of medical devices
Presentation: Life cycle of medical devicesPresentation: Life cycle of medical devices
Presentation: Life cycle of medical devicesTGA Australia
 
FDA Expectations for Traceability in Device & Diagnostic Design
FDA Expectations for Traceability in Device & Diagnostic DesignFDA Expectations for Traceability in Device & Diagnostic Design
FDA Expectations for Traceability in Device & Diagnostic DesignSeapine Software
 
Design and development of medical device
Design and development of medical deviceDesign and development of medical device
Design and development of medical deviceMalesh M
 
Medical Device Development - Trends, Challenges and Risks
Medical Device Development - Trends, Challenges and RisksMedical Device Development - Trends, Challenges and Risks
Medical Device Development - Trends, Challenges and RisksDina Sifri
 
Life Sciences Product Development
Life Sciences Product DevelopmentLife Sciences Product Development
Life Sciences Product Developmentwraylk
 
Fda quality system regulation 21 CFR820_Medical devices_k_trautman
Fda quality system regulation 21 CFR820_Medical devices_k_trautmanFda quality system regulation 21 CFR820_Medical devices_k_trautman
Fda quality system regulation 21 CFR820_Medical devices_k_trautmanLatvian University
 
Good design practice for medical devices
Good design practice for medical devicesGood design practice for medical devices
Good design practice for medical devicesJakob Nielsen
 
USA Commercial Strategy, Medical Devices, National Technology Transfer Confer...
USA Commercial Strategy, Medical Devices, National Technology Transfer Confer...USA Commercial Strategy, Medical Devices, National Technology Transfer Confer...
USA Commercial Strategy, Medical Devices, National Technology Transfer Confer...Debra A. Chanda
 
Mobile Medical Apps and FDA Regulatory Approach
Mobile Medical Apps and FDA Regulatory ApproachMobile Medical Apps and FDA Regulatory Approach
Mobile Medical Apps and FDA Regulatory ApproachAkshay Anand
 
Customer Requirement template
Customer Requirement templateCustomer Requirement template
Customer Requirement templateNoel Hatch
 
Is your medical device idea viable?
Is your medical device idea viable?Is your medical device idea viable?
Is your medical device idea viable?Carl Lincoln
 
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationDevices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationTGA Australia
 
Medical entrepreneurship
Medical entrepreneurshipMedical entrepreneurship
Medical entrepreneurshipJorge Saguinsin
 

Viewers also liked (20)

Medical device development lifecycle
Medical device development lifecycleMedical device development lifecycle
Medical device development lifecycle
 
Design control FDA requirements
Design control FDA requirementsDesign control FDA requirements
Design control FDA requirements
 
Systems Engineering and Requirements Management in Medical Device Product Dev...
Systems Engineering and Requirements Management in Medical Device Product Dev...Systems Engineering and Requirements Management in Medical Device Product Dev...
Systems Engineering and Requirements Management in Medical Device Product Dev...
 
Common Mistakes in the Medical Device Development Continuum
Common Mistakes in the Medical Device Development ContinuumCommon Mistakes in the Medical Device Development Continuum
Common Mistakes in the Medical Device Development Continuum
 
FDA Design Controls: What Medical Device Makers Need to Know
FDA Design Controls: What Medical Device Makers Need to KnowFDA Design Controls: What Medical Device Makers Need to Know
FDA Design Controls: What Medical Device Makers Need to Know
 
The Medical Device Milestone Map
The Medical Device Milestone MapThe Medical Device Milestone Map
The Medical Device Milestone Map
 
Presentation: Life cycle of medical devices
Presentation: Life cycle of medical devicesPresentation: Life cycle of medical devices
Presentation: Life cycle of medical devices
 
FDA Expectations for Traceability in Device & Diagnostic Design
FDA Expectations for Traceability in Device & Diagnostic DesignFDA Expectations for Traceability in Device & Diagnostic Design
FDA Expectations for Traceability in Device & Diagnostic Design
 
Design and development of medical device
Design and development of medical deviceDesign and development of medical device
Design and development of medical device
 
Medical Device Development - Trends, Challenges and Risks
Medical Device Development - Trends, Challenges and RisksMedical Device Development - Trends, Challenges and Risks
Medical Device Development - Trends, Challenges and Risks
 
Life Sciences Product Development
Life Sciences Product DevelopmentLife Sciences Product Development
Life Sciences Product Development
 
Fda quality system regulation 21 CFR820_Medical devices_k_trautman
Fda quality system regulation 21 CFR820_Medical devices_k_trautmanFda quality system regulation 21 CFR820_Medical devices_k_trautman
Fda quality system regulation 21 CFR820_Medical devices_k_trautman
 
Good design practice for medical devices
Good design practice for medical devicesGood design practice for medical devices
Good design practice for medical devices
 
USA Commercial Strategy, Medical Devices, National Technology Transfer Confer...
USA Commercial Strategy, Medical Devices, National Technology Transfer Confer...USA Commercial Strategy, Medical Devices, National Technology Transfer Confer...
USA Commercial Strategy, Medical Devices, National Technology Transfer Confer...
 
Mobile Medical Apps and FDA Regulatory Approach
Mobile Medical Apps and FDA Regulatory ApproachMobile Medical Apps and FDA Regulatory Approach
Mobile Medical Apps and FDA Regulatory Approach
 
Customer Requirement template
Customer Requirement templateCustomer Requirement template
Customer Requirement template
 
Is your medical device idea viable?
Is your medical device idea viable?Is your medical device idea viable?
Is your medical device idea viable?
 
Audits af QC lab
Audits af QC labAudits af QC lab
Audits af QC lab
 
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationDevices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulation
 
Medical entrepreneurship
Medical entrepreneurshipMedical entrepreneurship
Medical entrepreneurship
 

Similar to MEDICAL DEVICE DEVELOPMENT_0327

Investment Screen-Angel Investment
Investment Screen-Angel InvestmentInvestment Screen-Angel Investment
Investment Screen-Angel InvestmentRobert Stathopulos
 
Asia HealthTech Innovation - Philips | The Propell Group
Asia HealthTech Innovation - Philips | The Propell GroupAsia HealthTech Innovation - Philips | The Propell Group
Asia HealthTech Innovation - Philips | The Propell GroupJulien de Salaberry
 
[DSC Europe 23] Philipe Reinisch - Why new products still fail. Unlocking the...
[DSC Europe 23] Philipe Reinisch - Why new products still fail. Unlocking the...[DSC Europe 23] Philipe Reinisch - Why new products still fail. Unlocking the...
[DSC Europe 23] Philipe Reinisch - Why new products still fail. Unlocking the...DataScienceConferenc1
 
Asia HealthTech Investment Landscape - The Propell Group
Asia HealthTech Investment Landscape - The Propell GroupAsia HealthTech Investment Landscape - The Propell Group
Asia HealthTech Investment Landscape - The Propell GroupJulien de Salaberry
 
The Trouble with Innovation - TNS Sifo seminarium 2013
The Trouble with Innovation - TNS Sifo seminarium 2013The Trouble with Innovation - TNS Sifo seminarium 2013
The Trouble with Innovation - TNS Sifo seminarium 2013Kantar Sifo
 
Demystifying medical technology venture funding : Kapil Khandelwal, www.kapil...
Demystifying medical technology venture funding : Kapil Khandelwal, www.kapil...Demystifying medical technology venture funding : Kapil Khandelwal, www.kapil...
Demystifying medical technology venture funding : Kapil Khandelwal, www.kapil...Kapil Khandelwal (KK)
 
Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014healthtechqld
 
The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The Business Fame Magazine
 
Conference wrapup: Marketing Pharma Summit - Zurich
Conference wrapup: Marketing Pharma Summit - ZurichConference wrapup: Marketing Pharma Summit - Zurich
Conference wrapup: Marketing Pharma Summit - ZurichGSW
 
Rikas Investment Group's Corporate Brochure
Rikas Investment Group's Corporate BrochureRikas Investment Group's Corporate Brochure
Rikas Investment Group's Corporate BrochureDmitry Piltyay
 
How to Leverage Engineering & R&D From India and China in the Med Tech Business
How to Leverage Engineering & R&D From India and China in the Med Tech BusinessHow to Leverage Engineering & R&D From India and China in the Med Tech Business
How to Leverage Engineering & R&D From India and China in the Med Tech BusinessUBMCanon
 
Open innovation- Eli Lilly
Open innovation- Eli LillyOpen innovation- Eli Lilly
Open innovation- Eli LillyHetang Desai
 
Digitrends Company's Portfolio 2017
Digitrends Company's Portfolio 2017Digitrends Company's Portfolio 2017
Digitrends Company's Portfolio 2017Samad Saleem
 
LED Medical Diagnostics - Investor Presentation April 2014
LED Medical Diagnostics - Investor Presentation April 2014LED Medical Diagnostics - Investor Presentation April 2014
LED Medical Diagnostics - Investor Presentation April 2014Company Spotlight
 
Medical Device Reimbursement - Lean Startup Methodology
Medical Device Reimbursement - Lean Startup MethodologyMedical Device Reimbursement - Lean Startup Methodology
Medical Device Reimbursement - Lean Startup MethodologyAmir Inbar
 

Similar to MEDICAL DEVICE DEVELOPMENT_0327 (20)

Investment Screen-Angel Investment
Investment Screen-Angel InvestmentInvestment Screen-Angel Investment
Investment Screen-Angel Investment
 
Truth Biomedical
Truth BiomedicalTruth Biomedical
Truth Biomedical
 
Asia HealthTech Innovation - Philips | The Propell Group
Asia HealthTech Innovation - Philips | The Propell GroupAsia HealthTech Innovation - Philips | The Propell Group
Asia HealthTech Innovation - Philips | The Propell Group
 
New Orleans Bioinnovation Center
New Orleans Bioinnovation CenterNew Orleans Bioinnovation Center
New Orleans Bioinnovation Center
 
hitt - company profile-2015
hitt - company profile-2015hitt - company profile-2015
hitt - company profile-2015
 
[DSC Europe 23] Philipe Reinisch - Why new products still fail. Unlocking the...
[DSC Europe 23] Philipe Reinisch - Why new products still fail. Unlocking the...[DSC Europe 23] Philipe Reinisch - Why new products still fail. Unlocking the...
[DSC Europe 23] Philipe Reinisch - Why new products still fail. Unlocking the...
 
ttopstart brochure
ttopstart brochurettopstart brochure
ttopstart brochure
 
Asia HealthTech Investment Landscape - The Propell Group
Asia HealthTech Investment Landscape - The Propell GroupAsia HealthTech Investment Landscape - The Propell Group
Asia HealthTech Investment Landscape - The Propell Group
 
The Trouble with Innovation - TNS Sifo seminarium 2013
The Trouble with Innovation - TNS Sifo seminarium 2013The Trouble with Innovation - TNS Sifo seminarium 2013
The Trouble with Innovation - TNS Sifo seminarium 2013
 
Demystifying medical technology venture funding : Kapil Khandelwal, www.kapil...
Demystifying medical technology venture funding : Kapil Khandelwal, www.kapil...Demystifying medical technology venture funding : Kapil Khandelwal, www.kapil...
Demystifying medical technology venture funding : Kapil Khandelwal, www.kapil...
 
Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014Healthtech QLD Inaugural event 21 October 2014
Healthtech QLD Inaugural event 21 October 2014
 
Bellycare
BellycareBellycare
Bellycare
 
The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021The most recommended pharma & life sciences solution providers in 2021
The most recommended pharma & life sciences solution providers in 2021
 
Conference wrapup: Marketing Pharma Summit - Zurich
Conference wrapup: Marketing Pharma Summit - ZurichConference wrapup: Marketing Pharma Summit - Zurich
Conference wrapup: Marketing Pharma Summit - Zurich
 
Rikas Investment Group's Corporate Brochure
Rikas Investment Group's Corporate BrochureRikas Investment Group's Corporate Brochure
Rikas Investment Group's Corporate Brochure
 
How to Leverage Engineering & R&D From India and China in the Med Tech Business
How to Leverage Engineering & R&D From India and China in the Med Tech BusinessHow to Leverage Engineering & R&D From India and China in the Med Tech Business
How to Leverage Engineering & R&D From India and China in the Med Tech Business
 
Open innovation- Eli Lilly
Open innovation- Eli LillyOpen innovation- Eli Lilly
Open innovation- Eli Lilly
 
Digitrends Company's Portfolio 2017
Digitrends Company's Portfolio 2017Digitrends Company's Portfolio 2017
Digitrends Company's Portfolio 2017
 
LED Medical Diagnostics - Investor Presentation April 2014
LED Medical Diagnostics - Investor Presentation April 2014LED Medical Diagnostics - Investor Presentation April 2014
LED Medical Diagnostics - Investor Presentation April 2014
 
Medical Device Reimbursement - Lean Startup Methodology
Medical Device Reimbursement - Lean Startup MethodologyMedical Device Reimbursement - Lean Startup Methodology
Medical Device Reimbursement - Lean Startup Methodology
 

More from Robert Stathopulos

Nanobiz India Scouting Services
Nanobiz India Scouting ServicesNanobiz India Scouting Services
Nanobiz India Scouting ServicesRobert Stathopulos
 
Raising Capital for Medical Device Development
Raising Capital for Medical Device DevelopmentRaising Capital for Medical Device Development
Raising Capital for Medical Device DevelopmentRobert Stathopulos
 
RAISING CAPITAL FOR MEDICAL DEVICE DEVELOPMENT
RAISING CAPITAL FOR MEDICAL DEVICE DEVELOPMENTRAISING CAPITAL FOR MEDICAL DEVICE DEVELOPMENT
RAISING CAPITAL FOR MEDICAL DEVICE DEVELOPMENTRobert Stathopulos
 
Consulting Services to Medical Device Industry
Consulting Services to Medical Device IndustryConsulting Services to Medical Device Industry
Consulting Services to Medical Device IndustryRobert Stathopulos
 

More from Robert Stathopulos (6)

Nanobiz India Scouting Services
Nanobiz India Scouting ServicesNanobiz India Scouting Services
Nanobiz India Scouting Services
 
Raising Capital for Medical Device Development
Raising Capital for Medical Device DevelopmentRaising Capital for Medical Device Development
Raising Capital for Medical Device Development
 
RAISING CAPITAL FOR MEDICAL DEVICE DEVELOPMENT
RAISING CAPITAL FOR MEDICAL DEVICE DEVELOPMENTRAISING CAPITAL FOR MEDICAL DEVICE DEVELOPMENT
RAISING CAPITAL FOR MEDICAL DEVICE DEVELOPMENT
 
Consulting Services to Medical Device Industry
Consulting Services to Medical Device IndustryConsulting Services to Medical Device Industry
Consulting Services to Medical Device Industry
 
Consulting CV
Consulting CVConsulting CV
Consulting CV
 
Consulting Brochure
Consulting BrochureConsulting Brochure
Consulting Brochure
 

MEDICAL DEVICE DEVELOPMENT_0327

  • 1. 1 Raising Capital for Medical Device Development Challenges for Inventors and Investors Presented by ! Robert Stathopulos! ! President, Product Development Technology, Inc.! Sponsor & Advisor, Entrepreneurs University! ! 02 April 2013!
  • 2. Raising Capital for Medical Device Development 2© 2013 Product Development Technology, Inc. •  Established companies develop existing device iterations •  Start-up companies develop most new devices categories •  Innovation has outstripped ability to assess performance •  Dissemination of innovation delayed by outcomes validation Product Innovation
  • 3. Raising Capital for Medical Device Development 3 MEDICAL DEVICE DEVELOPMENT Low Impact on Clinical Utility High Impact on Clinical Utility MARGINAL INNOVATION 'Existing' Technology applied to 'Existing' Medical Use LOWEST UNCERTAINTY THERAPEUTIC INNOVATION 'Existing' Technology applied to 'New' Medical Use MEDIUM to HIGH UNCERTAINTY High Impact on Technology-in-Use Low Impact on Technology-in-Use TECHNOLOGICAL INNOVATION 'New' Technology applied to 'Existing' Medical Use LOW to MEDIUM UNCERTAINTY RADICAL INNOVATION 'New' Technology applied to 'New' Medical Use HIGHEST UNCERTAINTY © 2013 Product Development Technology, Inc. MODEL OF PRODUCT INNOVATION
  • 4. Raising Capital for Medical Device Development 4 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. "New" Medical Technology "Existing" Clinical Use "Existing" Medical Technology "Existing" Clinical Use "Existing" Medical Technology "New" Clinical Use "New" Medical Technology "New" Clinical Use HIGH LOW UNCERTAINTY SCALE "EXISTING" CLINICAL USE Domain "NEW" CLINICAL USE Domain LEVELS OF DEVELOPMENT RISK
  • 5. Raising Capital for Medical Device Development 5 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. LEVELS OF DEVELOPMENT RISK HIGH LOW UNCERTAINTY SCALE Plateau of Status Quo (We do not wish to change anything) Plateau of Utility Promotion (We find new means for old ways) Plateau of Everything Changes (We find new means with new ways) "EXISTING" CLINICAL USE Domain "NEW" CLINICAL USE Domain Plateau of Technology Promotion (We do it Smaller-Better- Faster-Cheaper)
  • 6. Raising Capital for Medical Device Development 6 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. LEVELS OF TECHNOLOGY READINESS Basic Principles Observed Speculative Application Formulated Critical Function Proof-of-Concept Breadboard Verification in Laboratory Breadboard Verification in Simulated Use System Prototype Verification in Simulated Use System Prototype Verification in Actual Use Final Product Validation in Actual Use Final Product Validation in Marketplace STEP #9 STEP #8 STEP #7 STEP #6 STEP #5 STEP #4 STEP #3 STEP #2 STEP #1 VERIFICATION PHASE FEASIBILITY PHASE
  • 7. Raising Capital for Medical Device Development 7 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. Inventor Venture Team Seed Investors Compliance Officers Device Users Patent Attorneys Key Suppliers Family Members Angel Investors WHAT KEEPS THE INVENTOR UP AT NIGHT?
  • 8. Raising Capital for Medical Device Development 8 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. WHAT KEEPS THE INVESTOR UP AT NIGHT? Inventor Angel Investors
  • 9. Raising Capital for Medical Device Development 9 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. INVENTOR PERSPECTIVE Compelling Product Concept Imperative: “Do It Right” Goal: “Get Product to Market” Supplies Vision and Perspiration
  • 10. Raising Capital for Medical Device Development 10 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. INVESTOR PERSPECTIVE Compelling Investment Opportunity! ! Imperative: “Get It Done”! " Goal: “Move Venture to Exit”" " Supplies Cash and Credibility"
  • 11. Raising Capital for Medical Device Development 11 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. INVENTOR + INVESTOR as THE ODD COUPLE
  • 12. Raising Capital for Medical Device Development 12 MEDICAL DEVICE DEVELOPMENT •  Evidence – Product Functions as Intended •  Evidence – Product has Clinical Utility •  Evidence – Product can be Profitable •  Evidence – Business Model is Scalable •  Evidence – Product has Proprietary Barrier •  Evidence – Development Path is Viable •  Evidence – Regulatory Path is Viable •  Evidence – Reimbursement Path is Viable •  Evidence – Venture Team is Competent •  Evidence – Venture Team has Skin-in-the-Game •  Evidence – Use of Proceeds will be Effective •  Evidence – Investor Exit is Plausible •  Evidence – Seed Stage Funding is Clean •  Evidence – Product Design is Documented © 2013 Product Development Technology, Inc. INVENTOR CHALLENGES
  • 13. Raising Capital for Medical Device Development 13 MEDICAL DEVICE DEVELOPMENT •  Will this Venture FIT into my PORTFOLIO? •  Are the Product and its Market REAL? •  Is the Technology behind the Product READY? •  Will the Product have the Cache to WIN? •  Is the Expected Return WORTH the Investment? •  Will the Venture Team meet its COMMITMENTS? •  Is there a viable path to US Market CLEARANCE? •  Is there a viable path to US REIMBURSEMENT? •  Will Due Diligence confirm the Inventor CLAIMS? © 2013 Product Development Technology, Inc. INVESTOR CHALLENGES
  • 14. Raising Capital for Medical Device Development 14 MEDICAL DEVICE DEVELOPMENT INVESTOR MINEFIELD •  Return on Investment based on liquidity event •  Novel Products tied to emerging or untried markets •  Venture is pre-revenue with no customer history •  Products in Development susceptible to market changes •  Product Knowledge held by very few •  Further Funding limited if key milestones missed •  Development Cycle has high cash-burn rate •  Venture Valuations are speculative or intuitive •  Minority Shareholders have little control •  Entrepreneurs poor at anticipating future problems © 2013 Product Development Technology, Inc.
  • 15. Raising Capital for Medical Device Development 15 MEDICAL DEVICE DEVELOPMENT INVENTOR MINEFIELD •  PATENT CLAIMS disallowance •  MARKET LANDSCAPE change •  REGULATORY LANDSCAPE change •  REIMBURSEMENT LANDSCAPE change •  PRODUCT COST escalation •  CLINICAL CLAIMS disallowance •  KEY SUPPLIER bankruptcy •  VENTURE FUNDING difficulties © 2013 Product Development Technology, Inc.
  • 16. Raising Capital for Medical Device Development 16 MEDICAL DEVICE DEVELOPMENT TYPES OF MEDICAL DEVICES © 2013 Product Development Technology, Inc. In-Vitro Diagnostic Device Medical Capital Equipment Medical Device Software Active Medical Device Disposable Medical Device Device Electronics Software Software Disposable Hardware SoftwareElectronics Disposable DisposableAssay SoftwareInstrument
  • 17. Raising Capital for Medical Device Development 17 MEDICAL DEVICE DEVELOPMENT DEVICE DEVELOPMENT PROCESS © 2013 Product Development Technology, Inc. CONCEPT DEVELOPMENT INVESTMENT GATE #2 INVESTMENT GATE #1 SEED ROUND FOUNDERS ROUND CONCEPT DEVELOPMENT PROTOTYPE DEVELOPMENT INVESTMENT GATE #2 INVESTMENT GATE #3 INVESTMENT GATE #1 SEED ROUND ANGEL ROUND 1 ANGEL ROUND 2 FOUNDERS ROUND CLASS II MEDICAL DEVICE CLASS III MEDICAL DEVICE 12 to 24 Months 12 to 24 Months 12 to 24 Months $250,000 $250,000 PRE-CLINICAL DEVELOPMENT ANGEL ROUND 2 ANGEL EXIT ANGEL ROUND 3 CORPORATE ACQUISITION 12 to 24 Months 24 to 48 Months PROTOTYPE DEVELOPMENT TECHNOLOGY DEVELOPMENT INVESTMENT GATE #3 12 to 24 Months12 to 24 Months GOVERNMENT GRANTS ANGEL ROUND 1 12 to 24 Months ANGEL EXIT CORPORATE ACQUISITION 36 to 72 Months (3 to 6 Years) 72 to 144 Months (6 to 12 Years) $2,000,000 to $3,000,000 $2,000,000 to $3,000,000 $250,000$250,000 INVESTMENT GATE #4 INVESTMENT GATE #5 $3,000,000 to $4,000,000 $3,500,000 to $5,000,000 CLINICAL DEVELOPMENT CLINICAL DEVELOPMENT $7,000,000 to $10,500,000 $1,000,000 to $2,000,000 $500,000 to $1,000,000 $1,000,000 to $1,500,000
  • 18. Raising Capital for Medical Device Development 18 MEDICAL DEVICE DEVELOPMENT DEVICE DEVELOPMENT PROCESS © 2013 Product Development Technology, Inc. CLINICAL DEVELOPMENT MANUFACTURING DEVELOPMENT MARKET DEVELOPMENT CORPORATE ACQUISITION PRODUCT INTRODUCTION INVESTOR EXITVC ROUND 1 VC ROUND 2 VC ROUND 3 12 to 24 Months 12 to 24 Months 12 to 24 Months External vs. Internal Manufacturing $2,000,000 to $5,000,000 $1,000,000 to $3,000,000 $1,000,000 to $3,000,000 External vs. Internal Sales Team Not Reimbursed to Reimbursed Funding Source Switch VENTURE CAPITALIST FUNDING > Later Stage Venture > Lower Risk Investment > Larger Investments ANGEL INVESTOR FUNDING > Early Stage Venture > Higher Risk Investment > Smaller Investments
  • 19. Raising Capital for Medical Device Development 19 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. PRE-MONEY VALUATION for EARLY STAGE VENTURE EXECUTION STRATEGY= = PRODUCT IDEA PRE-MONEY VALUATION $750,000 to $1,500,000 (Typically) Weak Idea 1 Fair Idea 5 Good Idea 10 Great Idea 15 Brillant Idea 20 Weak Execution $1,000 Fair Execution $10,000 Good Execution $100,000 Great Execution $1,000,000 Brillant Execution $10,000,000
  • 20. Raising Capital for Medical Device Development 20 MEDICAL DEVICE DEVELOPMENT CORPORATE ATTRACTION to EARLY STAGE VENTURE •  Exposure to emerging technology •  Access to specialized knowledge •  Understanding of emerging market •  Access to entrepreneurial talent •  Investment in potential acquisition •  Blocking competitor acquisition •  Access to new customer or distributor •  Access to complementary technology © 2013 Product Development Technology, Inc.
  • 21. Raising Capital for Medical Device Development 21 MEDICAL DEVICE DEVELOPMENT FINANCIAL VENTURE •  Exit Value based on ‘future profit generation’ •  Use Proceeds to drive growth •  Venture has revenue, profit, growth •  Profitability-Driven Acquisition •  Sale limited by profit- generating capability STRATEGIC VENTURE •  Exit Value based on ‘asset or capability’ •  Use Proceeds to build asset or capability •  Venture leverages acquirer’s operation; too costly or time- consuming to copy •  Synergy-Driven Acquisition •  Sale limited by business synergy effect CORPORATE VALUATION of EARLY STAGE VENTURE © 2013 Product Development Technology, Inc.
  • 22. Raising Capital for Medical Device Development 22© 2013 Product Development Technology, Inc. The Drama of ! REGULATORY APPROVAL ! & INSURANCE REIMBURSEMENT!
  • 23. Raising Capital for Medical Device Development 23 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. US REGULATORY PATHWAY PROTOTYPE DEVELOPMENT BENCH TESTING ANIMAL TESTING PRE-SUBMISSION MEETING PILOT CLINICAL US MARKET CLEARANCE IDE SUBMISSION IDE SUBMISSION PIVOTAL CLINICAL APPLICATION REVIEW US MARKET CLEARANCE APPLICATION REVIEW US MARKET APPROVAL > Traditional 510(k) > Special 510(k) > Abbreviated 510(k) > Traditional PMA > Modular PMA > Streamlined PMA > Product Development Protocol > Humanitarian Device Exemption > De Novo 510(k) CLASS I DEVICE CLASS II DEVICE (Not Significant Risk) CLASS II DEVICE (Significant Risk) CLASS III DEVICE 510(K) APPLICATION PMA APPLICATION
  • 24. Raising Capital for Medical Device Development 24 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. EU REGULATORY PATHWAY Select EC Directive Classify Medical Device Select ISO Certified Manufacturer Prepare Technical File or Design Dossier Select Notified Body Audit Technical File or Design Dossier Prepare Declaration of Conformity Affix CE Mark
  • 25. Raising Capital for Medical Device Development 25 MEDICAL DEVICE DEVELOPMENT CMS Scrutiny CLINICAL OUTCOME MEDICAL SAFETY ECONOMIC OUTCOME FDA Scrutiny MEDICAL SAFETY CLINICAL EFFICACY •  FDA validates safety and efficacy of new device •  CMS considers patient need and medical necessity •  CMS will not approve new costly procedure or device if current treatment gives similar outcome •  CMS will approve new device with demonstrably superior results •  CMS will approve new procedure if greatly needed and no current alternatives •  Health economics must justify more costly device with better patient outcome © 2013 Product Development Technology, Inc. INSURANCE REIMBURSEMENT
  • 26. Raising Capital for Medical Device Development 26 MEDICAL DEVICE DEVELOPMENT •  FDA Clearance insufficient for Reimbursement •  Reimbursement is success driver for new technology •  Medicine-Based Evidence ranks Quality of Evidence •  Clinical effectiveness of device for Patients •  Cost effectiveness of device for Stakeholders •  No guarantee for Coverage or sufficient Payment © 2013 Product Development Technology, Inc. INSURANCE REIMBURSEMENT BENEFITCOST TECHNOLOGY ASSESSMENT • PATIENT • PROVIDER • PURCHASER • PAYER • REGULATOR • SOCIETY • PATIENT • PROVIDER • PURCHASER • PAYER • REGULATOR • SOCIETY
  • 27. Raising Capital for Medical Device Development 27 MEDICAL DEVICE DEVELOPMENT •  Device receiving 510(k) Clearance is substantially equivalent to currently marketed product •  Device would fall under current reimbursement coverage, code and payment constraints •  Argument for higher payment for Device is illogical © 2013 Product Development Technology, Inc. INSURANCE REIMBURSEMENT REGULATORY PATHWAY REIMBURSEMENT PATHWAY Pathway Synchronization
  • 28. Raising Capital for Medical Device Development 28 MEDICAL DEVICE DEVELOPMENT © 2013 Product Development Technology, Inc. “If everything seems under control, you’re just not going fast enough.” --Mario Andretti